The global recombinant vaccines market size was valued at USD 11,507.3 million in 2021 and is poised to grow at a significant CAGR of 5.3% during the forecast period 2022-28. Increased prevalence of infectious diseases and increased technological advancements boost the growth of the recombinant vaccine market. Furthermore, increased regulatory approvals of recombinant vaccines also drive the...
0 Commentarios
0 Acciones
1414 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian